|Bid||1.5500 x 800|
|Ask||1.6000 x 900|
|Day's Range||1.5600 - 1.6200|
|52 Week Range||1.3000 - 3.2000|
|Beta (5Y Monthly)||1.59|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 09, 2021 - Nov 15, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.00|
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the first and only EPA registered rat contraceptive, ContraPest®, announced today revenues for the second quarter of 2021 increased 125% from the same period a year ago, and are up 82% sequentially. Year to date, revenues have increased 130% from the same period last year. The growth is driven by continued adoption of ContraPest across its key market segments an
SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, will report financial results for its second quarter 2021, ended June 30, 2021, after the market close on Thursday, August 12, 2021. The Company has scheduled a conference call that same day, Thursday, August 12, 2021, at 5:00 pm ET, to review the results.